| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2008-10-29 15:23:30 UTC |
|---|
| Update Date | 2021-09-14 15:45:34 UTC |
|---|
| HMDB ID | HMDB0011179 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Prolylphenylalanine |
|---|
| Description | Prolylphenylalanine is a dipeptide composed of proline and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It is found in urine (PMID: 3782411 ). |
|---|
| Structure | OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1 InChI=1S/C14H18N2O3/c17-13(11-7-4-8-15-11)16-12(14(18)19)9-10-5-2-1-3-6-10/h1-3,5-6,11-12,15H,4,7-9H2,(H,16,17)(H,18,19)/t11-,12-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| L-Pro-L-phe | ChEBI | | PF | ChEBI | | L-Prolyl-L-phenylalanine | HMDB | | N-L-Prolyl-L-phenylalanine | HMDB | | N-Prolylphenylalanine | HMDB | | p-F Dipeptide | HMDB | | PF Dipeptide | HMDB | | Pro-phe | HMDB | | Proline phenylalanine dipeptide | HMDB | | Proline-phenylalanine dipeptide | HMDB | | Prolyl-phenylalanine | HMDB | | Prolylphenylalanine | ChEBI |
|
|---|
| Chemical Formula | C14H18N2O3 |
|---|
| Average Molecular Weight | 262.309 |
|---|
| Monoisotopic Molecular Weight | 262.131742448 |
|---|
| IUPAC Name | (2S)-3-phenyl-2-{[(2S)-pyrrolidin-2-yl]formamido}propanoic acid |
|---|
| Traditional Name | (2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoic acid |
|---|
| CAS Registry Number | 13589-02-1 |
|---|
| SMILES | OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1 |
|---|
| InChI Identifier | InChI=1S/C14H18N2O3/c17-13(11-7-4-8-15-11)16-12(14(18)19)9-10-5-2-1-3-6-10/h1-3,5-6,11-12,15H,4,7-9H2,(H,16,17)(H,18,19)/t11-,12-/m0/s1 |
|---|
| InChI Key | IWIANZLCJVYEFX-RYUDHWBXSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Phenylalanine or derivatives
- N-acyl-alpha-amino acid
- Proline or derivatives
- N-acyl-alpha amino acid or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- 3-phenylpropanoic-acid
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine-2-carboxamide
- Benzenoid
- Monocyclic benzene moiety
- Pyrrolidine
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Secondary amine
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Secondary aliphatic amine
- Organic oxygen compound
- Organic oxide
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Amine
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.63 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.933 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.83 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 187.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1113.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 220.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 121.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 87.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 281.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 317.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 635.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 728.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 335.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 958.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 204.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 234.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 414.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 342.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 96.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Prolylphenylalanine,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1 | 2340.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,1TMS,isomer #2 | C[Si](C)(C)N(C(=O)[C@@H]1CCCN1)[C@@H](CC1=CC=CC=C1)C(=O)O | 2313.6 | Semi standard non polar | 33892256 | | Prolylphenylalanine,1TMS,isomer #3 | C[Si](C)(C)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O | 2341.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C | 2251.7 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C | 2277.7 | Standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C | 3051.9 | Standard polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C | 2286.8 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C | 2313.3 | Standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C | 3037.1 | Standard polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #3 | C[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 2277.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #3 | C[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 2351.2 | Standard non polar | 33892256 | | Prolylphenylalanine,2TMS,isomer #3 | C[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 3053.0 | Standard polar | 33892256 | | Prolylphenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C)[Si](C)(C)C | 2289.9 | Semi standard non polar | 33892256 | | Prolylphenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C)[Si](C)(C)C | 2374.3 | Standard non polar | 33892256 | | Prolylphenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C)[Si](C)(C)C | 2819.6 | Standard polar | 33892256 | | Prolylphenylalanine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1 | 2588.4 | Semi standard non polar | 33892256 | | Prolylphenylalanine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)[C@@H]1CCCN1)[C@@H](CC1=CC=CC=C1)C(=O)O | 2551.4 | Semi standard non polar | 33892256 | | Prolylphenylalanine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O | 2559.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C(C)(C)C | 2752.3 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C(C)(C)C | 2679.0 | Standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1)[Si](C)(C)C(C)(C)C | 3205.0 | Standard polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C | 2789.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C | 2724.3 | Standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C | 3223.1 | Standard polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2768.9 | Semi standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2731.8 | Standard non polar | 33892256 | | Prolylphenylalanine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1CCC[C@H]1C(=O)N([C@@H](CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3229.0 | Standard polar | 33892256 | | Prolylphenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2982.0 | Semi standard non polar | 33892256 | | Prolylphenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2950.3 | Standard non polar | 33892256 | | Prolylphenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H]1CCCN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3112.0 | Standard polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|